Our view remains unchanged: the results are good, the outlook does not look bad either but the stock is now too expensive and therefore we see limited upside for the moment.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Our view remains unchanged: the results are good, the outlook does not look bad either but the stock is now too expensive and therefore we see limited upside for the moment.
